When clinically appropriate, our Northeast Indianapolis providers may prescribe GLP-1 medications including semaglutide and tirzepatide as part of a physician-supervised weight loss program
10.1016/j.jtbi.2003.08.001 34 ReedM
In their most recent earnings reported in early August, Eli Lilly said Mounjaro and Zepbound brought in a combined $8.6 billion in Q2, and Novo Nordisk reported Ozempic and Wegovy brought in a combined $8 billion for the quarter
The OpenLoop Healthcare Partners, PC relationship means there's an established medical group structure with documented telehealth consent, state licensure, and compliance infrastructure behind the clinical services - not just a website with a prescriber on call
This approach makes stopping treatment a positive milestone rather than a setback
Murray S, Tulloch A, Gold MS, Avena NM